MediBeacon

MediBeacon

MediBeacon

We create novel light-activated agents to enable medical innovations. Our noninvasive real-time kidney function monitoring system is in human clinical trials.
Type
B2c
Raised
$41M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$10,000,000
Venture capital (Series C) - 2017
HC2 Holdings
$22,400,000
Venture capital (Series B) - 2015
Pansend
Team Size
1–10
Employees
$10,000,000 Venture capital (Series C)
bizjournals

http://www.bizjournals.com/stlouis/news/2017/03/27/new-york-firm-invests-another-10-million-in.html

$22,400,000 Venture capital (Series B)
FinSMEs

MediBeacon Receives $22.4M in Financing